Indicators of success

  1. Home
  2. >
  3. Results
  4. >
  5. Indicators of success
Indicator leaflets are a tool to evaluate the performance and impact of HBM4EU and link our key results to the objectives of the project as laid down in the description of the action. The different leaflets have been designed with illustrative character including maps, figures and infographics on methodology to be easily interpretable with more outreach to the larger public.

In total, we have 23 indicator leaflets (presented in D6.2 – Revised set of key indicators), including 1 overview leaflet on project output indicators and 22 leaflets linking to the 5 overarching objectives and specific goals of HBM4EU. They provide information for 28 indicators as some of them have been grouped on one leaflet.

The indicator leaflets give very valuable information on the progress of HBM4EU in relation to the specific goals of the project. Combining the information from these leaflets in the frame of expected impacts will allow us to put forward conclusions regarding the impact and sustainability of HBM4EU.

Please download the leaflets from this link.


Five additional leaflets have been developed to measure the impact of the project. Click on the preview below to access the impact leaflets:

Coordinated HBM initiatives
Nature and chemical exposure
EU-wide database
Increased awareness


Indicator NumberIndicator Title
1.1Number of countries with an active national hub
1.2Number of aligned human biomonitoring (HBM) studies within HBM4EU
2.1Number of biomarkers for which exposure distributions and/or reference values are calculated within HBM4EU
2.2Number of Human Biomonitoring Guidance Values (HBM-GVs) proposed by the HBM4EU consortium
2.3Number of references to HBM4EU related HBM data in risk assessment
3.1Number of candidate labs for chemical analysis, quality assurance/quality control (QA/QC) support and new analytical methods development
3.2Number of qualified labs for chemical analysis
3.3Number of exposure biomarkers covered in Interlaboratory Comparison Investigations (ICI) and External Quality Assessment Scheme (EQUAS)
4.1Number of scoping documents for prioritized substance groups
4.2Number of answers on rapid requests from policy makers
4.3Number of existing combinations of HBM and health surveys
5.1Number of human biomonitoring datasets available through IPCHeM
6.1Number of chemicals/priority substances for which external and internal modelling predictions have been made (as in WP12)
7.1Number of biomarkers of effect applied in joint HBM-studies within HBM4EU)
8.1Number of emerging (mixtures of) chemicals screened in human samples
9.1Number of priority groups and number of individual chemicals for which links between exposures and human health outcomes have been described in the frame of HBM4EU (using AOPs or exploiting cohort studies)
10.1Number of scientific training activities within consortium
11.1Number of stakeholder consultations at European level for input in key HBM4EU processes
11.2Number of science-policy interactions
11.3Number of users and page views on the HBM4EU website
11.4Number of followers on Twitter, Facebook and LinkedIn
11.5Number of HBM4EU publications
11.6Number of oral and poster publications
11.7Number of HBM4EU events
11.8Number of items and downloads in the online library (per category)
11.9Number of reports in non-scientific traditional media
11.10Number of published policy briefs
I.1Percentage of deliverables per year submitted on due date and accepted by the Commission
I.2Percentage of milestones reached at due date
ALL INDICATORSHBM4EU Figures from leaflets success indicators


The HBM4EU project was launched in 2016 with the aim of improving the collective understanding of human exposure to hazardous chemicals and developing HBM as an exposure assessment method. The project had €74m in funding and jointly implemented by 120 partners from 28 participating countries – 24 EU member states plus Norway, Switzerland, Iceland and Israel and the European Environment Agency. One of its aims was to ensure the sustainability of HBM in the EU beyond 2021. The project ended in June 2022. The website will not be updated any longer, except the page on peer reviewed publications, but will be online until 2032.